Off-label uses of the Pipeline embolization device: a review of the literature.
Publication/Presentation Date
6-1-2017
Abstract
The Pipeline embolization device (PED) is the most widely used flow diverter in endovascular neurosurgery. In 2011, the device received FDA approval for the treatment of large and giant aneurysms in the internal carotid artery extending from the petrous to the superior hypophyseal segments. However, as popularity of the device grew and neurosurgeons gained more experience, its use has extended to several other indications. Some of these off-label uses include previously treated aneurysms, acutely ruptured aneurysms, small aneurysms, distal circulation aneurysms, posterior circulation aneurysms, fusiform aneurysms, dissecting aneurysms, pseudoaneurysms, and even carotid-cavernous fistulas. The authors present a literature review of the safety and efficacy of the PED in these off-label uses.
Volume
42
Issue
6
First Page
4
Last Page
4
ISSN
1092-0684
Published In/Presented At
Patel, P. D., Chalouhi, N., Atallah, E., Tjoumakaris, S., Hasan, D., Zarzour, H., Rosenwasser, R., & Jabbour, P. (2017). Off-label uses of the Pipeline embolization device: a review of the literature. Neurosurgical focus, 42(6), E4. https://doi.org/10.3171/2017.3.FOCUS1742
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
28565978
Department(s)
Administration and Leadership
Document Type
Article